MYC and cancer: A recent study found that DPY30 promotes MYC, an oncogene that is deregulated in up to 70% of human cancers and critically associated with cancer metabolic reprogramming52, and regulates chromatin accessibility to enable the efficient binding of MYC to its genomic targets53.